$ATNX

Athenex Inc

  • NASDAQ/NGS (GLOBAL SELECT MARKET)
  • Health Technology
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$3.79 ▲0.531%

Extented Hours

VOLUME

652,114

DAY RANGE

3.735 - 3.85

52 WEEK

3.52 - 15.24

Join Discuss about ATNX with like-minded investors

profile
@maletone #StockTraders.NET
recently

something is going on in $ATNX just popped up on the radar

58 Replies 15 👍 9 🔥

SO
@soheil.n #StockTraders.NET
recently

as predicted...2nd flush reclaimed > @soheil.n said: $MITO is similar to $ATNX yesterday type 4 play..the flush has been recalimed

89 Replies 14 👍 10 🔥

SO
@soheil.n #StockTraders.NET
recently

$MITO is similar to $ATNX yesterday type 4 play..the flush has been recalimed

65 Replies 12 👍 11 🔥

profile
@maletone #StockTraders.NET
recently

$prpo, $atnx, $CHMA

72 Replies 12 👍 13 🔥

profile
@maletone #StockTraders.NET
recently

wish $atnx would bounce

55 Replies 15 👍 12 🔥

profile
@maletone #StockTraders.NET
recently

mostly covered $ATNX

78 Replies 11 👍 12 🔥

profile
@maletone #StockTraders.NET
recently

$atnx getting heavier

85 Replies 12 👍 15 🔥

profile
@maletone #StockTraders.NET
recently

hoping we can get a push on $ATNX through 4.90 - $5 to rehit

146 Replies 8 👍 6 🔥

profile
@maletone #StockTraders.NET
recently

no he got dumped on $atnx well actually both

125 Replies 15 👍 7 🔥

profile
@maletone #StockTraders.NET
recently

covered some $ATNX down here will add back on pops

147 Replies 12 👍 7 🔥

profile
@maletone #StockTraders.NET
recently

everybody looking at $RHE now we eat on $ATNX 😁

120 Replies 6 👍 8 🔥

profile
@maletone #StockTraders.NET
recently

do it $ATNX

51 Replies 12 👍 13 🔥

profile
@maletone #StockTraders.NET
recently

rinse and repeat covered some $ATNX again

116 Replies 13 👍 10 🔥

profile
@TraderXx #StockTraders.NET
recently

leaning heavily on $atnx

69 Replies 12 👍 12 🔥

SO
@soheil.n #StockTraders.NET
recently

there it does it again...reclaims most of the flush > @soheil.n said: $ATNX no position..but thus far looks like a type 4 play...flushes are getting bought

114 Replies 14 👍 10 🔥

SO
@soheil.n #StockTraders.NET
recently

$ATNX no position..but thus far looks like a type 4 play...flushes are getting bought

109 Replies 9 👍 15 🔥

profile
@maletone #StockTraders.NET
recently

next level $ATNX needs to break is $5

82 Replies 11 👍 8 🔥

profile
@TraderXx #StockTraders.NET
recently

lovely $ATNX

126 Replies 13 👍 10 🔥

profile
@maletone #StockTraders.NET
recently

coveredd some $ATNX down here

52 Replies 13 👍 8 🔥

profile
@TraderXx #StockTraders.NET
recently

$ATNX NERI VICE

95 Replies 11 👍 6 🔥

profile
@maletone #StockTraders.NET
recently

need $ATNX to drop below 5.20s

124 Replies 8 👍 15 🔥

profile
@TraderXx #StockTraders.NET
recently

$ATNX nice stabbed some ss

73 Replies 8 👍 7 🔥

PR
@proj8 #StockTraders.NET
recently

short watch $VERU $MVIS $ATNX

82 Replies 14 👍 7 🔥

SO
@soheil.n #StockTraders.NET
recently

watchlist: $OCGN, $DPW, $VERU, $ATNX.....also watching $SKLZ post earnings

105 Replies 10 👍 12 🔥

Key Metrics

Market Cap

412.09 M

Beta

0.34

Avg. Volume

1.27 M

Shares Outstanding

109.31 M

Yield

0%

Public Float

0

Next Earnings Date

2021-08-05

Next Dividend Date

Company Information

Founded in 2003, Athenex, Inc. is a global clinical stage biopharmaceutical company dedicated to becoming a leader in the discovery, development, and commercialization of next generation drugs for the treatment of cancer. Athenex is organized around three platforms, including an Oncology Innovation Platform, a Commercial Platform, and a Global Supply Chain Platform. The Company's current clinical pipeline is derived from four different platform technologies: (1) Orascovery, based on P-glycoprotein inhibitor, (2) Src kinase inhibition, (3) T-cell receptor-engineered T-cells (TCR-T), and (4) Arginine deprivation therapy. Athenex's employees worldwide are dedicated to improving the lives of cancer patients by creating more active and tolerable treatments. Athenex has offices in Buffalo and Clarence, New York; Cranford, New Jersey; Houston, Texas; Chicago, Illinois; Hong Kong; Taipei, Taiwan; multiple locations in Chongqing, China; Manchester, UK; Guatemala City, Guatemala and Buenos Aires, Argentina.

CEO: Johnson Lau

Website:

HQ: 1001 Main St Ste 600 Buffalo, 14203-1009 New York

Related News

  • Benzinga

    The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts

    27 Jul 2021, 11:48
  • Benzinga

    Athenex Inks Commercialization Pacts For Tirbanibulin In Australia, New Zealand

    26 Jul 2021, 14:02
  • Seeking Alpha

    Athenex stock jumps 7% on tirbanibulin licensing deal

    26 Jul 2021, 11:28
  • Intrado Digital Media

    Athenex Announces Additional Licensing Agreements for Tirbanibulin

    26 Jul 2021, 11:00
  • OpenPR

    U.S. Injectable Compounding Pharmacy Market Major Players Analysis - Central Admixture Pharmacy Services, Inc., Nephron Pharmaceuticals Corporation, QuVa Pharma, Olympia Pharmacy, ASP Cares, Fagron Compounding Pharmacies, Athenex, Inc.

    24 Jul 2021, 12:13